Disclosures for "Self-administration of Rozanolixizumab in Patients with Generalized Myasthenia Gravis: The MG0020 Study"
-
Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for janssen. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson Johnson.
-
Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Investments S.A.R.L. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orion Pharma Poland. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viatris Healthcare. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Connectmedica Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medycyna Praktyczna - Szkolenia s.c.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biofarm Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mylan Healthcare Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zaklady Farmaceutyczne Polpharma SA. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bonnier Healthcare Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer Polska Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Poland Sp. z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer AG. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for QAH Sp z o.o.. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aflofarm Farmacja Polska. Dr. Berkowicz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TVIP.
-
Artur Druzdz has nothing to disclose.
-
Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Gandhi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Gandhi has received research support from Akcea Therapeutics. The institution of Dr. Gandhi has received research support from UCB.
-
Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for johnson and johnson. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
-
Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kedrion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Zschüntzsch has received research support from Argenx. The institution of Dr. Zschüntzsch has received research support from European commission. The institution of Dr. Zschüntzsch has received research support from UCB.
-
Marion Boehnlein has stock in UCB.
-
Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has received personal compensation for serving as an employee of UCB Biosciences GmbH. Andreea Lavrov has stock in UCB Biosciences GmbH. An immediate family member of Andreea Lavrov has stock in UCB Biosciences GmbH.
-
Mr. Morris has received personal compensation for serving as an employee of UCB Pharma L.
-
Dr. Singh has nothing to disclose.
-
The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.